{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:06:51Z","timestamp":1777860411299,"version":"3.51.4"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Beh\u00e7et\u2019s disease (BD) is a persistent inflammatory vasculitis affecting various vessel types across multiple organ systems. It clinically presents recurrent oral and genital ulcers, ocular inflammation, and various skin manifestations. Etiology remains multifactorial, involving genetic susceptibility, immune system dysregulation, and environmental triggers such as infections. Intestinal involvement represents a rare but particularly severe form of BD, whose clinical features frequently resemble those of inflammatory bowel diseases (IBD), complicating differential diagnosis and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report a case of a 23-year-old male with progressive postprandial abdominal pain, diarrhea, and marked weight loss. His clinical history was notable for recurrent oral aphthae, genital ulcers, and perianal infections. Colonoscopic examination revealed circumferential ulceration, mucosal edema, contact bleeding, and significant narrowing of the ileocecal lumen. Histopathological analysis indicated chronic active inflammation in the absence of granulomas or definitive vasculitis. Infectious and neoplastic causes were systematically excluded. The patient was diagnosed with intestinal BD. Although initial therapy with infliximab yielded partial clinical improvement, drug-level monitoring revealed suboptimal trough levels, indicating secondary loss of response. Subsequently, treatment was transitioned to the Janus kinase (JAK) inhibitor upadacitinib, which led to full symptom resolution and mucosal healing on follow-up endoscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case underscores the diagnostic and therapeutic challenges associated with intestinal BD, especially in distinguishing it from Crohn\u2019s disease and addressing resistance to anti-TNF agents. Our findings suggest that JAK inhibitors like upadacitinib may offer a promising alternative for patients with refractory intestinal BD. Incorporating therapeutic drug monitoring into clinical practice allows for personalized, adaptive treatment adjustments, potentially improving long-term outcomes in complex cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1783949","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:22:45Z","timestamp":1771478565000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Successful upadacitinib treatment in anti-TNF-refractory intestinal Beh\u00e7et\u2019s disease: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Yanfen","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Pathology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minggang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, H. Lee Moffitt Cancer Center & Research Institute","place":["Tampa, FL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, China-Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(23)02629-6","article-title":"Beh\u00e7et's syndrome","volume":"403","author":"Emmi","year":"2024","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"110549","DOI":"10.1016\/j.clim.2025.110549","article-title":"Etiopathogenesis of Beh\u00e7et's disease: a systematic literature review","volume":"279","author":"Belfeki","year":"2025","journal-title":"Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1055\/a-2543-0982","article-title":"Activation of fibroblast in intestinal Beh\u00e7et's disease shown by 68Ga-FAPI-04 PET\/CT","volume":"64","author":"Liu","year":"2025","journal-title":"Nuklearmedizin"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1550551","DOI":"10.3389\/fimmu.2025.1550551","article-title":"Multiple aseptic abscesses and pulmonary involvement in a child with Behcet's disease phenotype: a case report","volume":"16","author":"Zheng","year":"2025","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1007\/s10067-025-07581-y","article-title":"Predictors of anti-TNF treatment failure in intestinal Behcet's disease: a multicenter retrospective cohort study","volume":"44","author":"Xu","year":"2025","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3904\/kjim.2024.349","article-title":"Impact of body mass index on clinical outcomes in intestinal Behcet's disease","volume":"40","author":"Park","year":"2025","journal-title":"Korean J Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1619065","DOI":"10.3389\/fped.2025.1619065","article-title":"Therapeutic effect of adalimumab in the treatment of intestinal Behcet's disease in children","volume":"13","author":"Gao","year":"2025","journal-title":"Front Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/art.43331","article-title":"Appendix vasculitis in a patient with intestinal Beh\u00e7et's disease","volume":"78","author":"Tian","year":"2026","journal-title":"Arthritis Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"10232","DOI":"10.4081\/dr.2025.10232","article-title":"Dermatological insight as the key to diagnosing intestinal Beh\u00e7et's disease misdiagnosed as Crohn's: a case report","volume":"17","author":"Giorgio","year":"2025","journal-title":"Dermatol Rep"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13023-024-03484-4","article-title":"Specific plasma metabolite profile in intestinal Beh\u00e7et's syndrome","volume":"20","author":"Hou","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.gastro.2025.07.020","article-title":"Early infliximab levels and clearance predict outcomes after infliximab rescue in acute severe ulcerative colitis: results from PREDICT-UC","volume":"170","author":"Li Wai Suen","year":"2026","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e3863","DOI":"10.1097\/MD.0000000000003863","article-title":"Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study","volume":"95","author":"Hibi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/rheumatology\/keae585","article-title":"Infliximab vs interferon-\u03b1 in the treatment of Beh\u00e7et's syndrome: clinical data from the BIO-BEH\u00c7ET'S randomized controlled trial","volume":"64","author":"Moots","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1485394","DOI":"10.3389\/fmed.2024.1485394","article-title":"Case report: vedolizumab in oral Crohn's disease: the downsides of a gut-specific therapy for a multi-site disease","volume":"11","author":"Harte","year":"2024","journal-title":"Front Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.3390\/jcm13226771","article-title":"Risk factors of reoperation in patients with intestinal Beh\u00e7et's disease treated by initial bowel resection","volume":"13","author":"Kim","year":"2024","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1483993","DOI":"10.3389\/fimmu.2024.1483993","article-title":"Case report: successful remission with upadacitinib in a young patient with anti-TNF-refractory intestinal Beh\u00e7et's disease","volume":"15","author":"Sha","year":"2024","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1242","DOI":"10.1002\/iid3.1242","article-title":"Coexistence of ankylosing spondylitis and Beh\u00e7et's disease: successful treatment with upadacitinib","volume":"12","author":"Kraev","year":"2024","journal-title":"Immun Inflamm Dis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1783949\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:22:46Z","timestamp":1771478566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1783949\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":17,"alternative-id":["10.3389\/fmed.2026.1783949"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1783949","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"article-number":"1783949"}}